Literature DB >> 3573988

Effect of water deprivation on the centrally-mediated hypertensive response to clonidine in freely moving, normotensive rats.

H Kawasaki, K Takasaki.   

Abstract

Effects of water deprivation on pressor responses to centrally and peripherally administered clonidine was investigated in freely moving, normotensive rats with chronic guide cannula and catheters implanted into the abdominal aorta via the femoral artery. In normal hydrated rats, intracerebroventricularly (i.c.v.) injected clonidine (10 and 20 micrograms) produced a dose-dependent and long-lasting rise in mean blood pressure (MBP) concomitant with a decrease in heart rate. However, a significant depressor response was not observed for up to 90 min. In 48 hr dehydrated rats, the pressor response to i.c.v. injected clonidine (10 and 20 micrograms) was significantly depressed and a depressor response appeared. Intravenously (i.v.) administered clonidine (25 micrograms/kg) in normal hydrated rats also produced a long-lasting pressor response following an initial rapid rise in MBP. The long-lasting pressor response to i.v. injected clonidine was abolished after water deprivation for 48 hr, whereas the initial rise in MBP was less affected. These results suggest that clonidine elicits centrally-mediated pressor response, which is influenced by body fluid volumes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3573988     DOI: 10.1016/0024-3205(87)90053-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

1.  Furosemide inhibits the centrally-mediated pressor response to clonidine in conscious, normotensive rats.

Authors:  H Kawasaki; S Nakamura; K Takasaki
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

2.  Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal.

Authors:  D B Vaupel; A S Kimes; E D London
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.